Health
Results: 4153-4164 of 9287

Monument Therapeutics Announces Appointment of Robert Radie as Chair and Heather Preston to Advisory Board

Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights

Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]






